Our Team

Leadership Team

Ajay Singh

Founder & CEO

Gyan Ranjan

Vice President - Operations

Pete Meyers

Chief Financial Officer

Dave Picard

Chief Commercial Officer

Chris Bihari

Vice President - Sales

Josh Mathew

Vice President - Product Innovation & Strategy

Madan Mohan Rao

Vice President - Quality & Compliance

Sumitra A Pillai

Vice President & Head - R & D

Ted Smolenski

Vice President - Business Development

Board Of Directors

Ajay Singh

Founder & CEO

Gyan Ranjan

Vice President - Operations

Ali J Satvat

Director - KKR

Arjun Oberoi

Managing Director - Everstone

Puncham Mukim

Managing Director - Everstone


On April 6, 2023, the U.S. Food and Drug Administration (FDA) issued a final decision ordering the withdrawal of the approval of Makena® (hydroxyprogesterone caproate injection, 250 milligrams (mg) per mL) and its generics. FDA recognizes that there is a supply of product that has already been distributed. Patients who have questions should talk to their healthcare provider. We recommend health care practitioners consider FDA’s conclusions.

If you have questions or concerns about receiving your therapy as prescribed, consult your healthcare provider.